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To the Editor: In their interesting review on Randall’s plaque,
Evan et al.1 go through a number of rodent models where
hypercalciuria with/without stones or nephrocalcinosis have
been observed, but do not form Randall’s plaque-like
structures. The list is incomplete, as they themselves pointed
out. In our opinion, the Nuf rat model should be added:2 this
rat has an activating mutation of the calcium-sensing
receptor, which leads to calcifications at various renal levels
and – of particular interest – in papillary ducts in up to 63%
of heterozygous animals. Whether Randall’s plaques exist in
such a model is not known and cannot be ascertained from
published pictures. Calcification interestingly occurs with no
associated hypercalciuria. This model is attractive in relation
to human idiopathic calcium stone disease (idiopathic
calcium nephrolithiasis). Quite recently, Soldati et al.3
showed that an activating polymorphism of the calcium-
sensing receptor is associated with hypercalciuria in idio-
pathic calcium nephrolithiasis, and Terranegra et al.4 have
reported that calcium-sensing receptor SNPs form a
haplotype block associated with idiopathic calcium nephro-
lithiasis and increase the risk of stones by as much as 3.36
times. Looking for the occurrence of Randall’s plaques in the
Nuf rat might therefore be highly rewarding.
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Randall’s plaque and renal injury
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To the Editor: In an excellent review of their recent work,
authors indicate that renal epithelial cells associated with the
interstitial plaques ‘invariably appear normal, as does the
cellular interstitium’.1 However, illustrations in their various
publications show a number of structural abnormalities.
Interstitium is enlarged with abundant collagen. Basement
membrane is thickened and at places multilamellate.
Dispersed in the basement membrane are crystals that often
encircle the renal tubules, which appear necrotic.
Authors found osteopontin in the matrix of interstitial
crystals. In normal human kidneys, osteopontin is localized
primarily to epithelial cells lining the distal nephrons and
ascending limbs of the loop of Henle.2 Interstitial localization
of osteopontin is quite abnormal and is seen only in the
injured kidneys.
Previous studies of the plaque have reported renal
epithelial injury manifested as excessive collagen in the
papillary interstitium, necrosis of the tubular epithelium, and
thickening of the tubular basal lamina.3 Randall himself
concluded that damage to the cells and interstitium preceded
plaque formation.4
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We disagree with Professor Khan.1
The interstitial space of idiopathic CaOx stone formers
(ICSF) is not enlarged, and medullary tubular basement
membrane thickness is not increased. Human papillary tip
interstitial volume normally exceeds that of rats (the most
commonly studied kidney).2 Because the method of
fixation (immersion vs perfusion) and patient age influence
medullary tubular basement membrane thickness,3,4 one
cannot call the medullary tubular basement membrane of
our ICSF (mean age¼ 49 years, immersion fixed tissue)
normal or abnormal.
Papillary biopsies of our ICSF do not show cell necrosis.
Haggitt and Pitcock, who Khan refers to, examined kidneys
from 100 randomly selected autopsies. Their Figure 6
legend describes postmortem degeneration, which is not
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unexpected because immersion in buffered neutral for-
malin, their technique, fixes full kidneys poorly. Similar
limitations affect Randall’s autopsy study, and all other
studies that used autopsy material to determine morpho-
logical changes in the kidneys of stone formers.
Increased interstitial osteopontin need not connote cell
injury. Osteopontin has multiple functions, including bone
formation. Vascular calcifications in coronary disease and
uremia share characteristics with embryonic bone forma-
tion and repair including osteopontin expression. Inter-
stitial osteopontin in ICSF may be linked to osteoblast-like
activity of the papillary interstitial cells, a hypothesis
suggested since 1942.5
In contrast to brushite, cystine, and obesity bypass
stone formers, ICSF, as we define them, have Randall’s
plaque and no evidence of cell injury.6
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Support vector machines versus
artificial neural network: Who is
the winner?
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To the Editor: The paper1 shows a relevant comparison
between support vector machines versus artificial neural
network (ANN). We think that support vector machine is a
very effective and promising method. Nevertheless, we think
that a different ANN approach should be used. In our
opinion, the authors should better explain what they mean by
ANN. In fact, ANN is a wide family of different algorithms
and methods. We could suppose that the ANN used in the
work is a Multi-Layer-Perceptron with Backpropagation
algorithm. In any case, stating ‘support vector machine
outperformed ANN’ by testing only one kind of ANN seems
not appropriate.
Besides, the authors say ‘training and testing should be
performed more than once and test set performances
averaged out, to reduce the variance of the performance
estimate’.
It is well known that every training performed by an ANN
is unique, owing to many intrinsic characteristics, as, for
example, the randomly selected starting weights.2 Every
training has its own history and results. If we average out
these results, changing the test-set each time, we find a
medium value of a particular kind of ANN. It is a statistical
measure of different things. It could be more interesting to
train several ANNs, test them once, and take the best. There
are many ways to understand whether the training and
testing subsets have been chosen correctly. For example, a
third subset of the database can be used as a validation set.3
We suggest that different ANN approaches and further
tests should be carried out before asserting ‘support vector
machine outperformed ANN’.
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We try to elucidate the issues raised in the Letter by
Tonello1 with the following points:
1. In Dal Moro et al.2 we adhered to what is the widely
most accepted structure for artificial neural network
(ANN), the multi-layer, feed-forward ANN trained via
the back-prop algorithm; the depth and width of the
structure (number of layers and of nodes per layer),
along with other parameters (thresholds and starting
weights) were modified. It is known that such an ANN
can interpolate even discontinuous functions hence its
structure is quite general, especially for the considered
problem.
2. As for the training method, we again adhered to a
statistically sound technique: for each fixed combina-
tion of the above structure/parameters, we ran several
simulations and performed proper averages; this is
necessary because the training is non-deterministic,
hence performing it once would yield statistically
unreliable outputs, as strongly motivated in Dal Moro
et al.2
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